• Veolity is the efficient way
    of reading chest CT studies.

     

  • Combine lung CAD,
    prior studies,
    and efficient reporting.

  • And your case is read

    in a heartbeat.

Veolity

Lung cancer screening: Veolity is the reading platform for high-throughput lung CT environments. Built upon years of clinical and technical experience from large screening trials, it provides important innovations to improve the reading workflow and diagnostic quality.
Read more...

Lung Cancer Screening in the USA

Lung cancer is the leading cause of cancer death in the U.S. Early detection is crucial in the fight against cancer. Accordingly, national recommendations for lung cancer screening among high-risk groups have recently been updated. What support do radiologists need to perform screening efficiently under these new conditions?

Advantages of Lung Cancer Screening with Veolity

News & Events

| WCLC 2024: Early detection of lung cancer with Veolity - much more than just AI

To celebrate its 50th anniversary, the IASLC invites you to the World Conference on Lung Cancer 2024, in San Diego,USA, from September 7 to 10, 2024. MeVis Medical Solutions AG is pleased to present Veolity- its all-in-one solution for CT lung cancer diagnostics.

Read more...
| ESTI 2024: Veolity - MeVis AI-based solution for early detection of lung cancer

The 30th annual meeting of the European Society of Thoracic Imaging (ESTI) will take place in Rom from May 9-11,2024.

MeVis will be presenting Veolity on-site.

Read more...
| ROEKO 2024: Low-dose-CT for lung cancer screening with Veolity LungRead - made in Germany

MeVis is pleased to present Veolity, its all-in-one solution for lung cancer screening, at this year's industry exhibition at the 105th German Radiology Congress (ROEKO).

Read more...

Contact Us

Comments about Veolity or this website? Choose from a variety of feedback options to contact us. Read more...

Schedule a meeting